Clinical Trials · NCT00804297

Octreotide for the Treatment of Sulfonylurea-Associated Hypoglycemia

Name: Octreotide for the Treatment of Sulfonylurea-Associated Hypoglycemia
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 3Octreotide

Phase: Phase 3
Recruitment status: Completed
Sponsor: Albert Einstein Healthcare Network
Enrollment: 40
Start date: Jun 2005
Locations: 1 site, United States
Primary endpoint: mean glucose level for the non-octreotide group is higher than the octreotide group

View Octreotide compound reference